Clinical Trial Update: A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of pregabalin for Painful Diabetic Neuropathy and Postherpetic Neuralgia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy
• Postherpetic Neuralgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Painful Diabetic Neuropathy and Post Herpetic Neuralgia | Phase 4 | Status: COMPLETED